home · filing · 0001558370-24-004842
8-K filed April 8, 2024, 7:59 PM ET
ticker NUTX
CIK 0001479681
leadership
confidence high
sentiment neutral
materiality 0.40
Nutex Health appoints Scott J. Saunders as independent director to fill vacancy
Nutex Health Inc.
Scott J. Saunders, age 61, appointed to Board effective April 11, 2024, replacing deceased director John Waters.
Board determined Saunders is independent under Nasdaq standards; term expires at 2024 Annual Meeting.
Saunders receives standard non-employee director compensation: $150,000 per year in monthly installments.
Saunders is Managing Director at Farlie Turner Gilbert, healthcare M&A advisor, with 30+ years in middle-market advisory.
No family relationships or material interests between Saunders and company officers under Reg S-K Item 404(a).
Executive movements
Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements .
Appointed
Scott J. Saunders
director
Effective 2024-04-11
Filed April 8, 2024, 7:59 PM ET
appointed Scott J. Saunders, age 61, to serve as a director of the Company for a term commencing on April 11, 2024
Key facts
Extracted from this filing and checked against the source text.
Executive change
SEC 8-K Item 5.02
confidence 1.0
Scott J. Saunders was appointed as director at Nutex Health Inc..
Action appointed
Role director
Exact text from the filing
appointed Scott J. Saunders, age 61, to serve as a director of the Company for a term commencing on April 11, 2024
View on SEC.gov
Source: SEC EDGAR
accession 0001558370-24-004842
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.